North America Dermatology Treatment Devices Market
시장 규모 (USD 10억)
연평균 성장률 :
%

![]() |
2025 –2032 |
![]() |
USD 1.80 Billion |
![]() |
USD 3.60 Billion |
![]() |
|
![]() |
|
North America Dermatology Treatment Devices Market Segmentation, by type (Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet), by application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing), by end user (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Others)- Industry Trends and Forecast to 2032
North America Dermatology Treatment Devices Market Size
- The North America Dermatology Treatment Devices Market was valued atUSD1.8 Billionin 2024and is expected to reachUSD3.6 Billionby 2032
- During the forecast period of 2025 to 2032 the market is likely to grow at aCAGR of 8.9%,primarily driven by the increasing prevalence of chronic diseases
- Key drivers of the North America Dermatology Treatment Devices Market include the rising prevalence of chronic diseases like diabetes, growing awareness of needle-stick injuries, and the demand for safer and more efficient blood sampling devices.
North America Dermatology Treatment Devices Market Analysis
- The increasing focus on minimizing needle-stick injuries in healthcare settings is driving the adoption of safety lancets as a safer alternative for blood sampling.
- The rise in chronic diseases, especially diabetes, is fueling the demand for blood glucose monitoring devices, including safety lancets, for at-home and clinical use.
- For instance, Innovations in lancet design, such as push-button mechanisms and pressure-activated features, are enhancing user comfort and safety, further contributing to market growth..
- Increasing awareness regarding safe and hygienic blood sampling techniques in both medical and home care settings is promoting the use of safety lancets.
- As healthcare infrastructure improves, especially in developing regions, the demand for advanced medical devices, including safety lancets, is expected to rise significantly.
Report Scope and North America Dermatology Treatment Devices Market Segmentation
Attributes |
North America Dermatology Treatment Devices Market Insights |
Segments Covered |
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
Key Market Players |
|
Market Opportunities |
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
North America Dermatology Treatment Devices Market Trends
“integration of smart technology and connectivity features”
- Enhanced Patient Monitoring and Data Collection: Smart safety lancets are equipped with features like integrated biosensors and Bluetooth connectivity, enabling real-time data transmission to digital health platforms. This facilitates continuous monitoring of blood parameters and supports proactive healthcare interventions.
- Improved Patient Compliance and Engagement: By connecting to mobile applications, these devices provide users with reminders, usage statistics, and health insights, thereby encouraging regular testing and adherence to treatment plans.
- Support for Remote Healthcare Services: The integration of smart technology aligns with the growing demand for telemedicine and home healthcare services, allowing healthcare providers to remotely monitor patients' health status and make informed decisions without the need for in-person visits.
North America Dermatology Treatment Devices Market Dynamics
Driver
“rising prevalence of chronic diseases”
- Increased Demand for Regular Blood Sampling: Chronic diseases require frequent blood tests to monitor parameters like glucose levels, cholesterol, and hemoglobin, leading to a higher need for safe and efficient blood sampling devices.
- Enhanced Patient Safety and Compliance: Safety lancets are designed to minimize the risk of needlestick injuries and cross-contamination, encouraging patients to adhere to regular testing schedules.
- Alignment with Healthcare Regulations: The adoption of safety lancets supports healthcare facilities in complying with stringent safety standards and infection control protocols, promoting their widespread use in clinical settings.
Opportunity
“development of sustainable and eco-friendly safety lancets”
- Environmental Impact Reduction: With increasing global emphasis on sustainability, manufacturers are innovating safety lancets using biodegradable materials and recyclable packaging to minimize medical waste.
- Regulatory Compliance and Market Demand: Adhering to environmental regulations and responding to consumer demand for eco-conscious products can enhance brand reputation and market share.
- Alignment with Healthcare Sustainability Goals: Integrating sustainable practices in product development aligns with the broader healthcare industry's shift towards greener solutions, potentially opening new market segments and partnerships.
Restraint/Challenge
“high cost of advanced lancet technologies”
- Increased Production Costs: Advanced safety lancets often incorporate features like adjustable penetration depths and ergonomic designs, which enhance user comfort and safety but also increase manufacturing expenses.
- Limited Accessibility in Developing Regions: The elevated costs of these advanced devices can make them less accessible in developing countries, where healthcare budgets are constrained, and cost-effective alternatives are preferred.
North America Dermatology Treatment Devices Market Scope
The market is segmented on the basis application, type, and end user.
Segmentation |
Sub-Segmentation |
By Application |
|
By Type |
|
By End User |
|
North America Dermatology Treatment Devices Market Regional Analysis
“North America is the Dominant Region in the North America Dermatology Treatment Devices Market”
- High Prevalence of Chronic Diseases: The region exhibits a significant incidence of chronic conditions like diabetes, cardiovascular diseases, and cancer. For instance, in the United States, approximately 6 out of 10 adults have at least one chronic disease, necessitating regular blood sampling for management and monitoring.
- Robust Healthcare Infrastructure and Reimbursement Policies: North America boasts advanced healthcare facilities and favorable reimbursement policies, facilitating the adoption of safety lancets. In Canada, initiatives such as the Disability Tax Credit for insulin users underscore the region's commitment to supporting individuals with chronic conditions
- Technological Advancements and Market Growth: The region is witnessing continuous innovation in safety lancet technologies, including features like adjustable penetration depths and ergonomic designs. This progression, coupled with a substantial patient base and increasing healthcare expenditure, positions North America to account for a significant share of the market's growth
“Asia-Pacific is Projected to Register the Highest Growth Rate in the North America Dermatology Treatment Devices Market”
- High Prevalence of Diabetes: Over 60% of the Asian population is living with diabetes, with China and India accounting for nearly half of this number. The Western Pacific region alone has more than 138.2 million people with diabetes, a number expected to rise to 201.8 million by 2035. This surge in diabetic cases necessitates frequent blood sampling, driving demand for safety lancets.
- Government Initiatives Promoting Screening: Countries like India and China are implementing large-scale health initiatives to combat chronic diseases. For instance, India's Union Health Ministry launched a program in 2023 aiming to screen 75 million people for hypertension and diabetes by 2025. Similarly, China's 'Healthy China 2030' initiative focuses on integrated diabetes management across urban and rural areas, further increasing the need for diagnostic tools like safety lancets.
- Advancements in Healthcare Infrastructure: Rapid urbanization and improvements in healthcare services across Asia-Pacific are enhancing access to medical diagnostics. The rising incidence of infectious diseases, such as malaria, dengue, and chikungunya, which require diagnostic testing, is also contributing to the increased demand for safety lancets in the region.
North America Dermatology Treatment Devices Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- F. Hoffmann-La Roche Ltd
- Becton, Dickinson and Company (BD)
- Terumo Medical Corporation
- Bayer AG
- HTL-STREFA S.A.
- Sarstedt AG & Co. KG
- Improve Medical Technology Co. Ltd
- Ypsomed AG
- Greiner Bio-One International GmbH
- Owen Mumford Ltd
- Smiths Medical
- Nipro Corporation
- Cardinal Health, Inc.
- Arkray Inc.
- Medline Industries, Inc.
Latest Developments in North America Dermatology Treatment Devices Market
- In 2021, FUJIFILM Corporation opened NURA, a medical screening center focusing on cancer screening in Bangalore, India. This medical screening center is operated by FUJIFILM DKH LLP (FUJIFILM DKH) and Dr. Kutty’s Healthcare (DKH). FUJIFILM DKH LLP (FUJIFILM DKH) is a joint venture of FUJIFILM and Dr. Kutty’s Healthcare (DKH), which runs hospitals and screening centers in India and the Middle East.
- In 2023, Astellas Pharma announced that it has entered into an agreement with Roche Diabetes Care Japan Co., Ltd. for the development and commercialization of Roche Diabetes Care’s world-renowned Accu-Chek Guide Me blood glucose monitoring system with advanced accuracy as a combined medical product with BlueStar.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.